All the news Showing 10 of 31 articles from: CoronavirusGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Govt rejects pharma giant Mylan’s proposal to test low-cost hepatitis drug combo against Covid The Print / 28 September 2020 International registries provide more information about COVID-19 and liver disease Liz Highleyman / 17 September 2020 People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver transplants do not appear to be at greater ... DCGI Rejects Mylan’s Request to Waive Phase 3 Trials for COVID-19 Drug Science Wire / 11 August 2020 EASL updates guidance on COVID-19 in liver disease patients Keith Alcorn / 11 August 2020 The European Association for the Study of the Liver (EASL) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have updated their guidance on chronic liver disease and COVID-19, issued in ... COVID-19 slows hepatitis elimination Keith Alcorn / 04 August 2020 Hepatitis elimination efforts are being severely affected by the COVID-19 pandemic in many settings, results of a 32-country survey by the World Hepatitis Alliance show. The survey of civil society hepatitis organisations and frontline ... Care of Patients with Liver Disease during the COVID-19 Pandemic EASL / 27 July 2020 COVID-19 Toolkit for liver patient associations EASL / 27 July 2020 How often does COVID-19 cause liver disorders? Keith Alcorn / 21 July 2020 Increases in liver enzymes are common in people with COVID-19 and occur more frequently in people with severe COVID-19, a meta-analysis of studies published in Hepatology International shows. Most liver enzyme elevations were ... Hepatitis C drugs may offer an inexpensive treatment option for COVID-19 Liz Highleyman / 20 July 2020 Sofosbuvir and daclatasvir, two antiviral drugs used to treat hepatitis C, were associated with faster recovery, shorter hospitalisation and improve survival among people with moderate or severe COVID-19, researchers reported this month at the ... Cirrhosis raises the risk of liver injury in COVID-19 patients Keith Alcorn / 13 July 2020 People with cirrhosis, especially those with diabetes or obesity, are more likely to suffer significant liver injury after contracting SARS-CoV-2 than others with chronic liver disease, Asian liver specialists report in a ... ← First123...4Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds